Pharming Group N.V.
PHAR
$8.51
-$0.07-0.82%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -177.14% | -170.97% | |
| Total Depreciation and Amortization | -- | -- | 25.14% | 17.85% | |
| Total Amortization of Deferred Charges | -- | -- | 22.78% | 304.49% | |
| Total Other Non-Cash Items | -- | -- | -322.78% | 43.83% | |
| Change in Net Operating Assets | -- | -- | -4,282.69% | -219.14% | |
| Cash from Operations | -- | -- | -177.04% | -169.00% | |
| Capital Expenditure | -- | -- | -4.43% | 69.65% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -2,010.29% | -3,595.34% | |
| Cash from Investing | -- | -- | -2,531.19% | -10,593.99% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -13.80% | -38.50% | |
| Issuance of Common Stock | -- | -- | 316.22% | 471.13% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -53.59% | 9.39% | |
| Cash from Financing | -- | -- | 79.14% | 103.76% | |
| Foreign Exchange rate Adjustments | -- | -- | 128.82% | 146.96% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -1,044.36% | -2,067.25% | |